Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 7 July 1995:
Vol. 269. no. 5220, pp. 81 - 83
DOI: 10.1126/science.7541555

Articles

Science, Vol 269, Issue 5220, 81-83
Copyright © 1995 by American Association for the Advancement of Science


articles

Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein

CL Yu, DJ Meyer, GS Campbell, AC Larner, C Carter-Su, J Schwartz, and R Jove

Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor 48109, USA.

Cytokines and growth factors induce tyrosine phosphorylation of signal transducers and activators of transcription (STATs) that directly activate gene expression. Cells stably transformed by the Src oncogene tyrosine kinase were examined for STAT protein activation. Assays of electrophoretic mobility, DNA-binding specificity, and antigenicity indicated that Stat3 or a closely related STAT family member was constitutively activated by the Src oncoprotein. Induction of this DNA-binding activity was accompanied by tyrosine phosphorylation of Stat3 and correlated with Src transformation. These findings demonstrate that Src can activate STAT signaling pathways and raise the possibility that Stat3 contributes to oncogenesis by Src.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Signal Transducer and Activator of Transcription 5b, c-Src, and Epidermal Growth Factor Receptor Signaling Play Integral Roles in Estrogen-Stimulated Proliferation of Estrogen Receptor-Positive Breast Cancer Cells.
E. M. Fox, T. M. Bernaciak, J. Wen, A. M. Weaver, M. A. Shupnik, and C. M. Silva (2008)
Mol. Endocrinol. 22, 1781-1796
   Abstract »    Full Text »    PDF »
Guggulsterone, a Farnesoid X Receptor Antagonist, Inhibits Constitutive and Inducible STAT3 Activation through Induction of a Protein Tyrosine Phosphatase SHP-1.
K. S. Ahn, G. Sethi, B. Sung, A. Goel, R. Ralhan, and B. B. Aggarwal (2008)
Cancer Res. 68, 4406-4415
   Abstract »    Full Text »    PDF »
Twist Is Transcriptionally Induced by Activation of STAT3 and Mediates STAT3 Oncogenic Function.
G. Z. Cheng, W. Zhang, M. Sun, Q. Wang, D. Coppola, M. Mansour, L. Xu, C. Costanzo, J. Q. Cheng, and L.-H. Wang (2008)
J. Biol. Chem. 283, 14665-14673
   Abstract »    Full Text »    PDF »
Signal Transducer and Activator of Transcription-3: A Molecular Hub for Signaling Pathways in Gliomas.
E. C. Brantley and E. N. Benveniste (2008)
Mol. Cancer Res. 6, 675-684
   Abstract »    Full Text »    PDF »
Functional dissection of transformation by c-Src and v-Src..
C. Oneyama, T. Hikita, S. Nada, and M. Okada (2008)
Genes Cells 13, 1-12
   Abstract »    Full Text »    PDF »
Tumor Suppressor LKB1 Inhibits Activation of Signal Transducer and Activator of Transcription 3 (STAT3) by Thyroid Oncogenic Tyrosine Kinase Rearranged in Transformation (RET)/Papillary Thyroid Carcinoma (PTC).
D. W. Kim, H. K. Chung, K. C. Park, J. H. Hwang, Y. S. Jo, J. Chung, D. V. Kalvakolanu, N. Resta, and M. Shong (2007)
Mol. Endocrinol. 21, 3039-3049
   Abstract »    Full Text »    PDF »
Anoikis, Initiated by Mcl-1 Degradation and Bim Induction, Is Deregulated during Oncogenesis.
N. T. Woods, H. Yamaguchi, F. Y. Lee, K. N. Bhalla, and H.-G. Wang (2007)
Cancer Res. 67, 10744-10752
   Abstract »    Full Text »    PDF »
ephrinB1 signals from the cell surface to the nucleus by recruitment of STAT3.
Y.-S. Bong, H.-S. Lee, L. Carim-Todd, K. Mood, T. G. Nishanian, L. Tessarollo, and I. O. Daar (2007)
PNAS 104, 17305-17310
   Abstract »    Full Text »    PDF »
STAT3 Signaling and the Hyper-IgE Syndrome.
D. E. Levy and C. A. Loomis (2007)
N. Engl. J. Med. 357, 1655-1658
   Full Text »    PDF »
Tumor Suppressive Protein Gene Associated with Retinoid-Interferon-Induced Mortality (GRIM)-19 Inhibits src-Induced Oncogenic Transformation at Multiple Levels.
S. Kalakonda, S. C. Nallar, P. Gong, D. J. Lindner, S. E. Goldblum, S. P. Reddy, and D. V. Kalvakolanu (2007)
Am. J. Pathol. 171, 1352-1368
   Abstract »    Full Text »    PDF »
Nucleocytoplasmic shuttling of persistently activated STAT3.
A. Herrmann, M. Vogt, M. Monnigmann, T. Clahsen, U. Sommer, S. Haan, V. Poli, P. C. Heinrich, and G. Muller-Newen (2007)
J. Cell Sci. 120, 3249-3261
   Abstract »    Full Text »    PDF »
Ursolic Acid Inhibits STAT3 Activation Pathway Leading to Suppression of Proliferation and Chemosensitization of Human Multiple Myeloma Cells.
A. K. Pathak, M. Bhutani, A. S. Nair, K. S. Ahn, A. Chakraborty, H. Kadara, S. Guha, G. Sethi, and B. B. Aggarwal (2007)
Mol. Cancer Res. 5, 943-955
   Abstract »    Full Text »    PDF »
Activated Signal Transducers and Activators of Transcription 3 Signaling Induces CD46 Expression and Protects Human Cancer Cells from Complement-Dependent Cytotoxicity.
R. Buettner, M. Huang, T. Gritsko, J. Karras, S. Enkemann, T. Mesa, S. Nam, H. Yu, and R. Jove (2007)
Mol. Cancer Res. 5, 823-832
   Abstract »    Full Text »    PDF »
Caffeic acid and its synthetic derivative CADPE suppress tumor angiogenesis by blocking STAT3-mediated VEGF expression in human renal carcinoma cells.
J. E. Jung, H. S. Kim, C. S. Lee, D.-H. Park, Y.-N. Kim, M.-J. Lee, J. W. Lee, J.-W. Park, M.-S. Kim, S. K. Ye, et al. (2007)
Carcinogenesis 28, 1780-1787
   Abstract »    Full Text »    PDF »
Tumor necrosis factor-{alpha} reduces argininosuccinate synthase expression and nitric oxide production in aortic endothelial cells.
B. L. Goodwin, L. C. Pendleton, M. M. Levy, L. P. Solomonson, and D. C. Eichler (2007)
Am J Physiol Heart Circ Physiol 293, H1115-H1121
   Abstract »    Full Text »    PDF »
EPS8 Facilitates Cellular Growth and Motility of Colon Cancer Cells by Increasing the Expression and Activity of Focal Adhesion Kinase.
M.-C. Maa, J.-C. Lee, Y.-J. Chen, Y.-J. Chen, Y.-C. Lee, S.-T. Wang, C.-C. Huang, N.-H. Chow, and T.-H. Leu (2007)
J. Biol. Chem. 282, 19399-19409
   Abstract »    Full Text »    PDF »
Capsaicin Is a Novel Blocker of Constitutive and Interleukin-6-Inducible STAT3 Activation.
M. Bhutani, A. K. Pathak, A. S. Nair, A. B. Kunnumakkara, S. Guha, G. Sethi, and B. B. Aggarwal (2007)
Clin. Cancer Res. 13, 3024-3032
   Abstract »    Full Text »    PDF »
The molecular basis of IL-21-mediated proliferation.
R. Zeng, R. Spolski, E. Casas, W. Zhu, D. E. Levy, and W. J. Leonard (2007)
Blood 109, 4135-4142
   Abstract »    Full Text »    PDF »
Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity.
K. Siddiquee, S. Zhang, W. C. Guida, M. A. Blaskovich, B. Greedy, H. R. Lawrence, M. L. R. Yip, R. Jove, M. M. McLaughlin, N. J. Lawrence, et al. (2007)
PNAS 104, 7391-7396
   Abstract »    Full Text »    PDF »
Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-{kappa}B-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells.
A. Bhardwaj, G. Sethi, S. Vadhan-Raj,, C. Bueso-Ramos, Y. Takada, U. Gaur, A. S. Nair, S. Shishodia, and B. B. Aggarwal (2007)
Blood 109, 2293-2302
   Abstract »    Full Text »    PDF »
Regulation of Metastases by Signal Transducer and Activator of Transcription 3 Signaling Pathway: Clinical Implications.
S. Huang (2007)
Clin. Cancer Res. 13, 1362-1366
   Abstract »    Full Text »    PDF »
PRL3 Promotes Cell Invasion and Proliferation by Down-regulation of Csk Leading to Src Activation.
F. Liang, J. Liang, W.-Q. Wang, J.-P. Sun, E. Udho, and Z.-Y. Zhang (2007)
J. Biol. Chem. 282, 5413-5419
   Abstract »    Full Text »    PDF »
Targeting Signal-Transducer-and-Activator-of-Transcription-3 for Prevention and Therapy of Cancer: Modern Target but Ancient Solution.
B. B. AGGARWAL, G. SETHI, K. S. AHN, S. K. SANDUR, M. K. PANDEY, A. B. KUNNUMAKKARA, B. SUNG, and H. ICHIKAWA (2006)
Ann. N.Y. Acad. Sci. 1091, 151-169
   Abstract »    Full Text »    PDF »
Newly identified c-KIT receptor tyrosine kinase ITD in childhood AML induces ligand-independent growth and is responsive to a synergistic effect of imatinib and rapamycin.
S. Corbacioglu, M. Kilic, M.-A. Westhoff, D. Reinhardt, S. Fulda, and K.-M. Debatin (2006)
Blood 108, 3504-3513
   Abstract »    Full Text »    PDF »
Elevated Activity of STAT3C due to Higher DNA Binding Affinity of Phosphotyrosine Dimer Rather than Covalent Dimer Formation.
L. Li and P. E. Shaw (2006)
J. Biol. Chem. 281, 33172-33181
   Abstract »    Full Text »    PDF »
SFK-STAT Pathway: An Alternative and Important Way to Malignancies.
F. HAYAKAWA and T. NAOE (2006)
Ann. N.Y. Acad. Sci. 1086, 213-222
   Abstract »    Full Text »    PDF »
A Preferential Role for STAT5, not Constitutively Active STAT3, in Promoting Survival of a Human Lymphoid Tumor.
Z. S. Nagy, H. Rui, S. M. Stepkowski, J. Karras, and R. A. Kirken (2006)
J. Immunol. 177, 5032-5040
   Abstract »    Full Text »    PDF »
Deguelin, an Akt Inhibitor, Suppresses I{kappa}B{alpha} Kinase Activation Leading to Suppression of NF-{kappa}B-Regulated Gene Expression, Potentiation of Apoptosis, and Inhibition of Cellular Invasion.
A. S. Nair, S. Shishodia, K. S. Ahn, A. B. Kunnumakkara, G. Sethi, and B. B. Aggarwal (2006)
J. Immunol. 177, 5612-5622
   Abstract »    Full Text »    PDF »
Modulation of Stat3 Activation by the Cytosolic Phospholipase A2{alpha} and Cyclooxygenase-2-controlled Prostaglandin E2 Signaling Pathway.
C. Han, A. J. Demetris, D. B. Stolz, L. Xu, K. Lim, and T. Wu (2006)
J. Biol. Chem. 281, 24831-24846
   Abstract »    Full Text »    PDF »
Wilms' Tumor 1 and Signal Transducers and Activators of Transcription 3 Synergistically Promote Cell Proliferation: A Possible Mechanism in Sporadic Wilms' Tumor.
Y. Rong, L. Cheng, H. Ning, J. Zou, Y. Zhang, F. Xu, L. Liu, Z. Chang, and X.-Y. Fu (2006)
Cancer Res. 66, 8049-8057
   Abstract »    Full Text »    PDF »
STAT3: A multifaceted oncogene.
D. E. Levy and G. Inghirami (2006)
PNAS 103, 10151-10152
   Full Text »    PDF »
Stat3 Cleavage by Caspases: IMPACT ON FULL-LENGTH Stat3 EXPRESSION, FRAGMENT FORMATION, AND TRANSCRIPTIONAL ACTIVITY.
J. W. Darnowski, F. A. Goulette, Y.-j. Guan, D. Chatterjee, Z.-F. Yang, L. P. Cousens, and Y. E. Chin (2006)
J. Biol. Chem. 281, 17707-17717
   Abstract »    Full Text »    PDF »
Plumbagin (5-Hydroxy-2-methyl-1,4-naphthoquinone) Suppresses NF-{kappa}B Activation and NF-{kappa}B-regulated Gene Products Through Modulation of p65 and I{kappa}B{alpha} Kinase Activation, Leading to Potentiation of Apoptosis Induced by Cytokine and Chemotherapeutic Agents.
S. K. Sandur, H. Ichikawa, G. Sethi, K. S. Ahn, and B. B. Aggarwal (2006)
J. Biol. Chem. 281, 17023-17033
   Abstract »    Full Text »    PDF »
Activation of Stat3 in Human Melanoma Promotes Brain Metastasis..
T.-x. Xie, F.-J. Huang, K. D. Aldape, S.-H. Kang, M. Liu, J. E. Gershenwald, K. Xie, R. Sawaya, and S. Huang (2006)
Cancer Res. 66, 3188-3196
   Abstract »    Full Text »    PDF »
Cyclin d1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3..
K. Leslie, C. Lang, G. Devgan, J. Azare, M. Berishaj, W. Gerald, Y. B. Kim, K. Paz, J. E. Darnell, C. Albanese, et al. (2006)
Cancer Res. 66, 2544-2552
   Abstract »    Full Text »    PDF »
Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein..
A. Kotha, M. Sekharam, L. Cilenti, K. Siddiquee, A. Khaled, A. S. Zervos, B. Carter, J. Turkson, and R. Jove (2006)
Mol. Cancer Ther. 5, 621-629
   Abstract »    Full Text »    PDF »
A Constitutively Active Lck Kinase Promotes Cell Proliferation and Resistance to Apoptosis through Signal Transducer and Activator of Transcription 5b Activation.
M. Shi, J. C. Cooper, and C.-L. Yu (2006)
Mol. Cancer Res. 4, 39-45
   Abstract »    Full Text »    PDF »
Persistent Activation of Stat3 Signaling Induces Survivin Gene Expression and Confers Resistance to Apoptosis in Human Breast Cancer Cells.
T. Gritsko, A. Williams, J. Turkson, S. Kaneko, T. Bowman, M. Huang, S. Nam, I. Eweis, N. Diaz, D. Sullivan, et al. (2006)
Clin. Cancer Res. 12, 11-19
   Abstract »    Full Text »    PDF »
Activation of Stat3 in Primary Tumors from High-Risk Breast Cancer Patients Is Associated with Elevated Levels of Activated Src and Survivin Expression.
N. Diaz, S. Minton, C. Cox, T. Bowman, T. Gritsko, R. Garcia, I. Eweis, M. Wloch, S. Livingston, E. Seijo, et al. (2006)
Clin. Cancer Res. 12, 20-28
   Abstract »    Full Text »    PDF »
Molecular Cloning and Characterization of the Human AKT1 Promoter Uncovers Its Up-regulation by the Src/Stat3 Pathway.
S. Park, D. Kim, S. Kaneko, K. M. Szewczyk, S. V. Nicosia, H. Yu, R. Jove, and J. Q. Cheng (2005)
J. Biol. Chem. 280, 38932-38941
   Abstract »    Full Text »    PDF »
Diabetes Alters the Occupancy of the Hepatic 3-Hydroxy-3-methylglutaryl-CoA Reductase Promoter.
W. R. Lagor, E. D. de Groh, and G. C. Ness (2005)
J. Biol. Chem. 280, 36601-36608
   Abstract »    Full Text »    PDF »
Src Family Kinase Activity Is Required for Murine Embryonic Stem Cell Growth and Differentiation.
M. A. Meyn III, S. J. Schreiner, T. P. Dumitrescu, G. J. Nau, and T. E. Smithgall (2005)
Mol. Pharmacol. 68, 1320-1330
   Abstract »    Full Text »    PDF »
Src Inhibits Adriamycin-Induced Senescence and G2 Checkpoint Arrest by Blocking the Induction of p21waf1.
A. Vigneron, I. B. Roninson, E. Gamelin, and O. Coqueret (2005)
Cancer Res. 65, 8927-8935
   Abstract »    Full Text »    PDF »
The G{alpha}o/i-coupled Cannabinoid Receptor-mediated Neurite Outgrowth Involves Rap Regulation of Src and Stat3.
J. C. He, I. Gomes, T. Nguyen, G. Jayaram, P. T. Ram, L. A. Devi, and R. Iyengar (2005)
J. Biol. Chem. 280, 33426-33434
   Abstract »    Full Text »    PDF »
A Novel Platinum Compound Inhibits Constitutive Stat3 Signaling and Induces Cell Cycle Arrest and Apoptosis of Malignant Cells.
J. Turkson, S. Zhang, L. B. Mora, A. Burns, S. Sebti, and R. Jove (2005)
J. Biol. Chem. 280, 32979-32988
   Abstract »    Full Text »    PDF »
Role of Stat3 in Regulating p53 Expression and Function.
G. Niu, K. L. Wright, Y. Ma, G. M. Wright, M. Huang, R. Irby, J. Briggs, J. Karras, W. D. Cress, D. Pardoll, et al. (2005)
Mol. Cell. Biol. 25, 7432-7440
   Abstract »    Full Text »    PDF »
Composition and Assembly of STAT-Targeting Ubiquitin Ligase Complexes: Paramyxovirus V Protein Carboxyl Terminus Is an Oligomerization Domain.
C. M. Ulane, A. Kentsis, C. D. Cruz, J.-P. Parisien, K. L. Schneider, and C. M. Horvath (2005)
J. Virol. 79, 10180-10189
   Abstract »    Full Text »    PDF »
Stat3 Is Required for Full Neoplastic Transformation by the Simian Virus 40 Large Tumor Antigen.
A. Vultur, R. Arulanandam, J. Turkson, G. Niu, R. Jove, and L. Raptis (2005)
Mol. Biol. Cell 16, 3832-3846
   Abstract »    Full Text »    PDF »
Malignant Transformation but not Normal Cell Growth Depends on Signal Transducer and Activator of Transcription 3.
K. Schlessinger and D. E. Levy (2005)
Cancer Res. 65, 5828-5834
   Abstract »    Full Text »    PDF »
Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells.
S. Nam, R. Buettner, J. Turkson, D. Kim, J. Q. Cheng, S. Muehlbeyer, F. Hippe, S. Vatter, K.-H. Merz, G. Eisenbrand, et al. (2005)
PNAS 102, 5998-6003
   Abstract »    Full Text »    PDF »
Farnesyl Transferase Inhibitor (R115777)-Induced Inhibition of STAT3(Tyr705) Phosphorylation in Human Pancreatic Cancer Cell Lines Require Extracellular Signal-Regulated Kinases.
K. Venkatasubbarao, A. Choudary, and J. W. Freeman (2005)
Cancer Res. 65, 2861-2871
   Abstract »    Full Text »    PDF »
Cutting Edge: IL-10-Independent STAT3 Activation by Toxoplasma gondii Mediates Suppression of IL-12 and TNF-{alpha} in Host Macrophages.
B. A. Butcher, L. Kim, A. D. Panopoulos, S. S. Watowich, P. J. Murray, and E. Y. Denkers (2005)
J. Immunol. 174, 3148-3152
   Abstract »    Full Text »    PDF »
Expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Expression of Vascular Endothelial Growth Factor in and Angiogenic Phenotype of Human Gastric Cancer.
W. Gong, L. Wang, J. C. Yao, J. A. Ajani, D. Wei, K. D. Aldape, K. Xie, R. Sawaya, and S. Huang (2005)
Clin. Cancer Res. 11, 1386-1393
   Abstract »    Full Text »    PDF »
Hepatitis C Virus (HCV) Constitutively Activates STAT-3 via Oxidative Stress: Role of STAT-3 in HCV Replication.
G. Waris, J. Turkson, T. Hassanein, and A. Siddiqui (2005)
J. Virol. 79, 1569-1580
   Abstract »    Full Text »    PDF »
Novel Roles of Unphosphorylated STAT3 in Oncogenesis and Transcriptional Regulation.
J. Yang, M. Chatterjee-Kishore, S. M. Staugaitis, H. Nguyen, K. Schlessinger, D. E. Levy, and G. R. Stark (2005)
Cancer Res. 65, 939-947
   Abstract »    Full Text »    PDF »
Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity.
J. Turkson, S. Zhang, J. Palmer, H. Kay, J. Stanko, L. B. Mora, S. Sebti, H. Yu, and R. Jove (2004)
Mol. Cancer Ther. 3, 1533-1542
   Abstract »    Full Text »    PDF »
Central Role of the Threonine Residue within the p+1 Loop of Receptor Tyrosine Kinase in STAT3 Constitutive Phosphorylation in Metastatic Cancer Cells.
Z.-l. Yuan, Y.-j. Guan, L. Wang, W. Wei, A. B. Kane, and Y. E. Chin (2004)
Mol. Cell. Biol. 24, 9390-9400
   Abstract »    Full Text »    PDF »
Regulation of Signal Transducer and Activator of Transcription 1 (STAT1) and STAT1-Dependent Genes by RET/PTC (Rearranged in Transformation/Papillary Thyroid Carcinoma) Oncogenic Tyrosine Kinases.
E. S. Hwang, D. W. Kim, J. H. Hwang, H. S. Jung, J. M. Suh, Y. J. Park, H. K. Chung, J. H. Song, K. C. Park, S. H. Park, et al. (2004)
Mol. Endocrinol. 18, 2672-2684
   Abstract »    Full Text »    PDF »
Alternative Activation of STAT1 and STAT3 in Response to Interferon-{gamma}.
Y. Qing and G. R. Stark (2004)
J. Biol. Chem. 279, 41679-41685
   Abstract »    Full Text »    PDF »
SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION: INSIGHTS INTO THE MOLECULAR BASIS OF ORAL CANCER.
H. Siavash, N.G. Nikitakis, and J.J. Sauk (2004)
Crit. Rev. Oral. Biol. Med. 15, 298-307
   Abstract »    Full Text »    PDF »
Drosophila C-Terminal Src Kinase Negatively Regulates Organ Growth and Cell Proliferation through Inhibition of the Src, Jun N-Terminal Kinase, and STAT Pathways.
R. D. Read, E. A. Bach, and R. L. Cagan (2004)
Mol. Cell. Biol. 24, 6676-6689
   Abstract »    Full Text »    PDF »
Oxidized Phospholipids Increase Interleukin 8 (IL-8) Synthesis by Activation of the c-src/Signal Transducers and Activators of Transcription (STAT)3 Pathway.
M. Yeh, N. M. Gharavi, J. Choi, X. Hsieh, E. Reed, K. P. Mouillesseaux, A. L. Cole, S. T. Reddy, and J. A. Berliner (2004)
J. Biol. Chem. 279, 30175-30181
   Abstract »    Full Text »    PDF »
Oct-1 Maintains an Intermediate, Stable State of HLA-DRA Promoter Repression in Rb-defective Cells: AN Oct-1-CONTAINING REPRESSOSOME THAT PREVENTS NF-Y BINDING TO THE HLA-DRA PROMOTER.
A. R. Osborne, H. Zhang, G. Fejer, K. M. Palubin, M. I. Niesen, and G. Blanck (2004)
J. Biol. Chem. 279, 28911-28919
   Abstract »    Full Text »    PDF »
Pyk2 Amplifies Epidermal Growth Factor and c-Src-induced Stat3 Activation.
C.-S. Shi and J. H. Kehrl (2004)
J. Biol. Chem. 279, 17224-17231
   Abstract »    Full Text »    PDF »
Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity.
J. Turkson, J. S. Kim, S. Zhang, J. Yuan, M. Huang, M. Glenn, E. Haura, S. Sebti, A. D. Hamilton, and R. Jove (2004)
Mol. Cancer Ther. 3, 261-269
   Abstract »    Full Text »
AG490 inhibits G1-S traverse in BALB/c-3T3 cells following either mitogenic stimulation or exogenous expression of E2F-1.
J. Savell, Y. Ma, K. S. Morrow, R. Jove, N. Olashaw, P. L. Moseley, W. D. Cress, and W. Wharton (2004)
Mol. Cancer Ther. 3, 205-213
   Abstract »    Full Text »    PDF »
The Role of Signal Transducer and Activator of Transcription Factors in Leukemogenesis.
D. W. Sternberg and D. G. Gilliland (2004)
J. Clin. Oncol. 22, 361-371
   Abstract »    Full Text »    PDF »
Hyperactivation of STAT3 Is Involved in Abnormal Differentiation of Dendritic Cells in Cancer.
Y. Nefedova, M. Huang, S. Kusmartsev, R. Bhattacharya, P. Cheng, R. Salup, R. Jove, and D. Gabrilovich (2004)
J. Immunol. 172, 464-474
   Abstract »    Full Text »    PDF »
Specific Inhibition of Stat5a/b Promotes Apoptosis of IL-2-Responsive Primary and Tumor-Derived Lymphoid Cells.
F. Behbod, Z. S. Nagy, S. M. Stepkowski, J. Karras, C. R. Johnson, W. D. Jarvis, and R. A. Kirken (2003)
J. Immunol. 171, 3919-3927
   Abstract »    Full Text »    PDF »
Curcumin (Diferuloylmethane) Inhibits Constitutive and IL-6-Inducible STAT3 Phosphorylation in Human Multiple Myeloma Cells.
A. C. Bharti, N. Donato, and B. B. Aggarwal (2003)
J. Immunol. 171, 3863-3871
   Abstract »    Full Text »    PDF »
Sequence-specific Peptide Aptamers, Interacting with the Intracellular Domain of the Epidermal Growth Factor Receptor, Interfere with Stat3 Activation and Inhibit the Growth of Tumor Cells.
C. Buerger, K. Nagel-Wolfrum, C. Kunz, I. Wittig, K. Butz, F. Hoppe-Seyler, and B. Groner (2003)
J. Biol. Chem. 278, 37610-37621
   Abstract »    Full Text »    PDF »
Src Kinases Mediate STAT Growth Pathways in Squamous Cell Carcinoma of the Head and Neck.
S. Xi, Q. Zhang, K. F. Dyer, E. C. Lerner, T. E. Smithgall, W. E. Gooding, J. Kamens, and J. R. Grandis (2003)
J. Biol. Chem. 278, 31574-31583
   Abstract »    Full Text »    PDF »
Targeted Expression of c-Src in Epidermal Basal Cells Leads to Enhanced Skin Tumor Promotion, Malignant Progression, and Metastasis.
T. Matsumoto, J. Jiang, K. Kiguchi, L. Ruffino, S. Carbajal, L. Beltran, D. K. Bol, M. P. Rosenberg, and J. DiGiovanni (2003)
Cancer Res. 63, 4819-4828
   Abstract »    Full Text »    PDF »
The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3.
J. Zhang, J. Yang, S. K. Roy, S. Tininini, J. Hu, J. F. Bromberg, V. Poli, G. R. Stark, and D. V. Kalvakolanu (2003)
PNAS 100, 9342-9347
   Abstract »    Full Text »    PDF »
Stat5 Synergizes with T Cell Receptor/Antigen Stimulation in the Development of Lymphoblastic Lymphoma.
J. A. Kelly, R. Spolski, P. E. Kovanen, T. Suzuki, J. Bollenbacher, C. A. Pise-Masison, M. F. Radonovich, S. Lee, N. A. Jenkins, N. G. Copeland, et al. (2003)
J. Exp. Med. 198, 79-89
   Abstract »    Full Text »    PDF »
STAT Protein Interference and Suppression of Cytokine Signal Transduction by Measles Virus V Protein.
H. Palosaari, J.-P. Parisien, J. J. Rodriguez, C. M. Ulane, and C. M. Horvath (2003)
J. Virol. 77, 7635-7644
   Abstract »    Full Text »    PDF »
STAT-1 and c-Fos interaction in nitric oxide synthase-2 gene activation.
W. Xu, S. A. A. Comhair, S. Zheng, S. C. Chu, J. Marks-Konczalik, J. Moss, S. J. Haque, and S. C. Erzurum (2003)
Am J Physiol Lung Cell Mol Physiol 285, L137-L148
   Abstract »    Full Text »    PDF »
STAT3 Ubiquitylation and Degradation by Mumps Virus Suppress Cytokine and Oncogene Signaling.
C. M. Ulane, J. J. Rodriguez, J.-P. Parisien, and C. M. Horvath (2003)
J. Virol. 77, 6385-6393
   Abstract »    Full Text »    PDF »
Activation of Signal Transducer and Activator of Transcription 3 by Oncogenic RET/PTC (Rearranged in Transformation/Papillary Thyroid Carcinoma) Tyrosine Kinase: Roles in Specific Gene Regulation and Cellular Transformation.
J. H. Hwang, D. W. Kim, J. M. Suh, H. Kim, J. H. Song, E. S. Hwang, K. C. Park, H. K. Chung, J. M. Kim, T.-H. Lee, et al. (2003)
Mol. Endocrinol. 17, 1155-1166
   Abstract »    Full Text »    PDF »
Matrix-independent Activation of Phosphatidylinositol 3-Kinase, Stat3, and Cyclin A-associated Cdk2 Is Essential for Anchorage-independent Growth of v-Ros-transformed Chicken Embryo Fibroblasts.
S. Uttamsingh, C. S. Zong, and L.-H. Wang (2003)
J. Biol. Chem. 278, 18798-18810
   Abstract »    Full Text »    PDF »
Kaposi sarcoma-associated viral cyclin K overrides cell growth inhibition mediated by oncostatin M through STAT3 inhibition.
A. Lundquist, B. Barre, F. Bienvenu, J. Hermann, S. Avril, and O. Coqueret (2003)
Blood 101, 4070-4077
   Abstract »    Full Text »    PDF »
Fes Tyrosine Kinase Promotes Survival and Terminal Granulocyte Differentiation of Factor-dependent Myeloid Progenitors (32D) and Activates Lineage-specific Transcription Factors.
J. Kim, Y. Ogata, and R. A. Feldman (2003)
J. Biol. Chem. 278, 14978-14984
   Abstract »    Full Text »    PDF »
Signal transducer and activator of transcription proteins in leukemias.
M. Benekli, M. R. Baer, H. Baumann, and M. Wetzler (2003)
Blood 101, 2940-2954
   Abstract »    Full Text »